Celecoxib-induced aquagenic keratoderma;Queratodermia acuagénica inducida por celecoxib

Actas Dermo-Sifiliograficas

Volumn 96, Issue 8, 2005, Pages 537-539

  Vildósola, Susana ^a,c   Ugalde, Aitziber ^b  

^a HOSPITAL DE GALDAKAO   (Spain)

^b HOSPITAL DE MENDARO   (Spain)

^c NONE   (Spain)

Author keywords

Aquagenic keratoderma; Celecoxib

Indexed keywords

CELECOXIB; ROFECOXIB;

ADULT; AQUAGENIC KERATODERMA; ARTICLE; CASE REPORT; CYSTIC FIBROSIS; DRUG INDUCED DISEASE; EXPOSURE; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; KERATODERMA; PAPULE; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION; SWEAT GLAND; SYMPTOMATOLOGY;

EID: 29044439983     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(05)73129-x     Document Type: Article

References (13)

1. English JC, McCollough ML. Transient reactive papulotraslucent acrokeratoderma. J Am Acad Dermatol. 1996;34:686-7.
2. Lowes MA, Khaira GS, Holt D. Transient reactive papulotraslucent acrokeratoderma associated with cystic fibrosis. Australas J Dermatol. 2000;41:172-4.
3. Yan AC, Aasi SZ, Alms WJ, et al. Aqueagenic palmoplantar keratoderma. J Am Acad Dermatol. 2001;44:696-9.
4. MacCormack MA, Wiss K, Malhotra R. Aquagenic syringeal acrokeratoderma: repot of two teenage cases. J Am Acad Dermatol. 2001;45:125-6.
5. Carder KR, Weston WL. Rofecoxib-induced instant aquagenic wrinkling of the palms. Pediatr Dermatol. 2002;19:353-5.
6. Itin PH, Lautenschlager S. Aquagenic syringeal acrokeratoderma (transient reacive papulotranslucent acrokeratoderma). Dermatology. 2002;204:8-11.
7. Betlloch I, Vergara G, Albares MP, PascualJC, Silvestre JF, Botella R. Aquagenia keratoderma. JEADV. 2003;17:306-7.
8. Hawkey CJ. COX-2 inhibitors. Lancet. 1999;353:307-14.
9. Müller-Decker K, Reinet G, Krieg P, et al. Prostaglandin-Hsynthase isozyme expression in normal and neoplastic human skin. Int J Cancer. 1999;82:648-56.
10. Pentland AP. Arachidonic acid metabolism. En: Freedberg IM, Eisen AZ, Wolf K, et al, editors. Dermatology in general medicina. Nueva York: McGraw-Hill; 1999.
11. Catella-Lawson F, MacAdam B, Morrison BW, et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther. 1999;289:735-41.
12. Johns MK. Skin wrinkling un cystic fibrosis. Med Biol Ilustr. 1975;25:205-10.
13. Schmutz JL, Barbaud A, Trechot P. Rofecoxib-induced aquagenic edema with puckering of the palms of hands: the firt case. Ann Dermatol Venereol. 2003;130:813.